Article links:
Bookmark and Share

Evaluation of antigens for vaccination against liver fluke in cattle and buffalo in Indonesia

Project ID

AS1/1990/049

Project Country

Commissioned Organisation

Monash University, Department of Biochemistry and Molecular Biology, Australia

Project Leader

Dr Andrew Milner

Phone: 

820 0588

Fax: 

867 8560

Collaborating Institutions

Department of Agriculture and Rural Affairs, Research Institute for Veterinary Science (Balitvet), Indonesia

Project Budget

$1,097,023.00

Start Date

01/07/1992

Finish Date

30/06/1995

Extension Start Date

30/06/1995

Extension Finish Date

31/12/1997

ACIAR Research Program Manager

Dr John Copland

Overview Objectives

The Victorian Institute of Animal Science (VIAS) is developing a recombinant vaccine against Fasciola hepatica (liver fluke) infection in cattle and sheep and will be used to develop a suitable vaccine for F. gigantica - a closely related, tropical species of liver fluke affecting cattle and buffalo in Indonesia, Southeast Asia, the Pacific Islands and Africa.

A vaccine with 80-90% efficacy should be sufficient to reduce fluke burdens in Indonesia to levels that have minimal effect on meat production and work output.

Project Background and Objectives

F. gigantica infection of cattle and buffalo - characterised by weight loss, anaemia, reduced productivity, and reduced reproductive performance - is the third most important livestock disease in Indonesia. Estimates of economic loss caused by fluke infection range from A$58m to A$200m annually.

The group at VIAS is using a multi-disciplinary approach to study liver fluke, with molecular biologists, protein chemists and parasitologists analysing, testing and cloning fluke antigens. They have identified two antigens - glutathione- S-transferase (GST) and an immunoglobulin cleaving (protease) enzyme (ICE) - that can significantly protect sheep against F. hepatica infection.

A third set of antigens - integral membrane proteins (IMPs) - are also effective in retarding fluke growth in sheep. The group has demonstrated that F. gigantica possesses similar GST and ICE antigens, and is situated to purify the F. gigantica homologues quickly before testing them in vaccine trials with cattle and buffalo in Indonesia.

Location

There are no project locations defined for this project.